TABLE.

Comparison Between Number of Anti-VEGF Injections Between Ischemia Groups

	Follow-up Interval (Months)
Group	0–6	6–12	12–24	24–36	36–48	48–60
Total	5.9 ± 0.3	4.9 ± 1.6	3.9 ± 3.3	3.8 ± 3.3	3.2 ± 3.5	2.4 ± 3.5
0 (n = 46)	5.9 ± 0.4	4.8 ± 1.3	3.6 ± 3.3	3.2 ± 2.9	3.3 ± 3.3	1.8 ± 2.9
1 (n = 5)	6.0 ± 0.0	4.8 ± 1.6	2.6 ± 3.7	1.8 ± 2.5	2.2 ± 3.2	2.2 ± 3.5
2 (n = 189)	5.9 ± 1.0	5.0 ± 2.0	3.9 ± 3.3	3.9 ± 3.4	3.3 ± 3.6	2.8 ± 3.8
3 (n = 70)	5.9 ± 1.4	4.9 ± 2.2	4.1 ± 3.4	3.9 ± 3.4	2.8 ± 3.7	1.6 ± 2.9
P value	.79	.60	.74	.43	.74	.31

Anti-VEGF = anti–vascular endothelial growth factor.

Values are reported in mean ± SD.